openPR Logo
Press release

Hereditary Angioedema Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

04-25-2025 01:23 PM CET | Health & Medicine

Press release from: The Business Research Company

Hereditary Angioedema Market Size

Hereditary Angioedema Market Size

The Hereditary Angioedema Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Hereditary Angioedema Market?
Recent years have seen a solid increase in the hereditary angioedema market size. It is projected that this market will expand from $2.62 billion in 2024 to $2.84 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.7%. This significant growth throughout the historic period can be ascribed to an increased incidence of hereditary angioedema, heightened investment in research and development, a surge in drug approvals, an escalation in product approval, alongside a rising disposable income.

Anticipated robust expansion is predicted for the hereditary angioedema market in the forthcoming years. By 2029, it is projected to reach $3.93 billion, with a compound annual growth rate (CAGR) of 8.4%. This surge during the predicted period is due to factors such as the increased occurrence of uncommon diseases, rising healthcare expenditure, amplified assistance from non-profit entities, heightened awareness regarding hereditary angioedema, and growing consciousness early diagnosis. In the same forecast period, key trends encompass technological progress, the inception of innovative therapies, the introduction of new pharmaceuticals, state-of-the-art diagnostic instruments, and improvements in genetic testings.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22002

What Are the Different Hereditary Angioedema Market Segments?
The hereditary angioedema market covered in this report is segmented -

1) By Type: Hereditary Angioedema Type I, Hereditary Angioedema Type II
2) By Treatment Type: Prophylaxis, On-demand
3) By Drug Class: C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors, Other Drug Classes
4) By Route Of Administration: Subcutaneous, Intravenous, Oral
5) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Hereditary Angioedema Type I: C1-Inhibitor Deficiency, Low C1-Inhibitor Levels, Reduced C1-Inhibitor Function
2) By Hereditary Angioedema Type II: Normal C1-Inhibitor Levels, Dysfunctional C1-Inhibitor, Genetic Mutations In SERPING1 Gene

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22002&type=smp

What Are the Primary Drivers Shaping the Hereditary Angioedema Market?
The hereditary angioedema market is anticipated to grow due to the rising incidence of rare or orphan diseases, categorized as such due to their affliction of only a small proportion of the population. Numerous causes, including advances in medical research, fluctuations in population demographics, and environmental influences, contribute to the escalation of these rare diseases. Hereditary angioedema (HAE) is a noteworthy rare disease that causes serious swelling episodes, necessitating the development of exclusive treatments and enhanced awareness due to its life-threatening potential. Its infrequency and genetic origin necessitate early detection and tailored treatments for effective control and improved patient outcomes. The Rare Disease Advisor, a US-based virtual resource company for healthcare professionals, reported in June 2022 that hereditary angioedema (HAE) affects roughly one in 50,000 individuals, with disorder prevalence estimates varying from one in 10,000 to one in 150,000. Approximately 15,000-30,000 emergency room visits annually in the United States are due to HAE episodes. Consequently, the escalating prevalence of rare diseases is fueling the growth of the hereditary angioedema market.

Which Companies Are Leading in the Hereditary Angioedema Market?
Major companies operating in the hereditary angioedema market are Intellia Therapeutics Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Otsuka Pharmaceutical Co. Ltd., CSL Limited, Cipla Limited, BioMarin Pharmaceutical Inc., Ionis Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Spark Therapeutics Inc., Pharming Group N.V., Pharvaris N.V., Astria Therapeutics Inc., CENTOGENE N.V., KalVista Pharmaceuticals Inc., ADARx Pharmaceuticals Inc., Adverum Biotechnologies Inc., Attune Pharmaceuticals Inc., Lev Pharmaceuticals Inc.

What Are the Major Trends Shaping the Hereditary Angioedema Market?
Prominent organizations involved in the hereditary angioedema market are focusing on the creation of pioneering products like oral plasma kallikrein inhibitors that offer more practical and potent on-demand treatment options for sufferers. These inhibitors are medications that obstruct plasma kallikrein to impede the overproduction of bradykinin primarily for hereditary angioedema treatment. For example, KalVista Pharmaceuticals, Inc., an American pharmaceutical firm, declared in September 2024 that the FDA has given its approval to its new drug application (NDA) for a drug called sebetralstat. Developed as an oral plasma kallikrein inhibitor, it is designed for the as-needed treatment of hereditary angioedema (HAE) attacks in adults and children 12 years and older. By targeting and inhibiting the plasma kallikrein activity, sebetralstat introduces a novel treatment strategy. The NDA's acceptance signals a significant leap towards possible approval and market introduction.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-global-market-report

What Are the Top Revenue-Generating Geographies in the Hereditary Angioedema Market?
North America was the largest region in the hereditary angioedema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Hereditary Angioedema Market?
2. What is the CAGR expected in the Hereditary Angioedema Market?
3. What Are the Key Innovations Transforming the Hereditary Angioedema Industry?
4. Which Region Is Leading the Hereditary Angioedema Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hereditary Angioedema Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities here

News-ID: 3988270 • Views:

More Releases from The Business Research Company

Global Ayurvedic Herbal Extract Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Global Ayurvedic Herbal Extract Market Outlook 2025-2034: Trends, Innovations, A …
The Ayurvedic Herbal Extract Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Ayurvedic Herbal Extract Market Size and Projected Growth Rate? The ayurvedic herbal extract market has grown strongly in recent years. It will increase from $48.47 billion in 2024 to $52.25 billion
Automotive Wheel Rims Market Anticipated To Witness Robust Growth, Surpassing $60.75 Billion By 2029
Automotive Wheel Rims Market Anticipated To Witness Robust Growth, Surpassing $6 …
The Automotive Wheel Rims Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Automotive Wheel Rims Market Size and Its Estimated Growth Rate? The automotive wheel rims market has shown strong growth in recent years. It will expand from $41.87 billion in 2024
Impact Of Rising Road Accidents On The Automotive Testing, Inspection, And Certification (TIC) Market: An Emerging Driver Transforming The Automotive Testing, Inspection And Certification (TIC) Market Landscape
Impact Of Rising Road Accidents On The Automotive Testing, Inspection, And Certi …
The Automotive Testing, Inspection And Certification (TIC) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Automotive Testing, Inspection And Certification (TIC) Market? The automotive testing, inspection, and certification (TIC) market has seen strong growth in recent years. It will
Automotive Refinish Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
Automotive Refinish Industry Report 2025-2034: Market Dynamics, Trends, And Fore …
The Automotive Refinish Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Automotive Refinish Market Size During the Forecast Period? The automotive refinish market has experienced strong growth in recent years. It will rise from $12.39 billion in 2024 to $13.28 billion in

All 5 Releases


More Releases for Hereditary

Hereditary Angioedema Therapeutics Market - Forecast to 2026
As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead. Browse 153 Market Data Tables and 113 Figures spread through
Hereditary Testing Market Size – Forecasts to 2026
The results analyzed by GME showed that the Global Hereditary Testing Market will grow with a CAGR value of 7.1 percent, to hit xx billion USD by 2026. During the forecast timeframe, growth is expected to be driven by growing expenditure on R&D activities and the rising incidence of chronic diseases worldwide. The development may be attributed to the advancement of genetic testing services and the growing demand for personalized
Potential Opportunities of Hereditary Angioedema Treatment Market
The global hereditary angioedema treatment market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, "Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025." As per the report, the global hereditary angioedema treatment
Hereditary Angioedema Market Global Comprehensive Research 2020
Global Hereditary Angioedema Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Hereditary Angioedema Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes
Hereditary Angioedema Market Current Overview by 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html Superior Healthcare